GPS Wealth Strategies Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-336
Closed -$163K – 1482
2025
Q3
$163K Sell
336
-7
-2% -$3.26K 0.02% 388
2025
Q2
$139K Sell
343
-20
-6% -$8.36K 0.02% 387
2025
Q1
$181K Buy
363
+91
+33% +$49.3K 0.02% 318
2024
Q4
$142K Sell
272
-4
-1% -$2.2K 0.02% 359
2024
Q3
$171K Buy
276
+1
+0.4% +$592 0.02% 336
2024
Q2
$152K Buy
275
+31
+13% +$17.8K 0.02% 312
2024
Q1
$142K Hold
244
– – 0.02% 309
2023
Q4
$130K Hold
244
– – 0.02% 308
2023
Q3
$124K Hold
244
– – 0.02% 318
2023
Q2
$127K Buy
244
+4
+2% +$2.16K 0.02% 316
2023
Q1
$138K Buy
+240
New +$135K 0.03% 288
2022
Q4
– Sell
-240
Closed -$122K – 987
2022
Q3
$122K Buy
240
+3
+1% +$1.68K 0.03% 272
2022
Q2
$129K Buy
237
+62
+35% +$34.1K 0.03% 273
2022
Q1
$103K Buy
175
+115
+192% +$66.1K 0.02% 307
2021
Q4
$40K Sell
60
-20
-25% -$12.5K 0.01% 448
2021
Q3
$46K Sell
80
-76
-49% -$41.7K 0.01% 405
2021
Q2
$79K Hold
156
– – 0.02% 336
2021
Q1
$71K Buy
+156
New +$74.5K 0.02% 333

Other funds holding TMO

GPS Wealth Strategies Group's TMO Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 336 shares — an estimated $163K sold.

GPS Wealth Strategies Group first reported a position in TMO in Q1 2021 and held it in 18 quarters. The position peaked at $181K in Q1 2025. 2,707 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 336 Thermo Fisher Scientific shares in Q4 2025, an estimated $163K.
  • GPS Wealth Strategies Group first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 18 quarters.
  • GPS Wealth Strategies Group's Thermo Fisher Scientific position peaked at $181K in Q1 2025.
  • 2,707 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.